We demonstrated here that this protein is one of the main players in the effects of DADS in SKBR3 cells, although very few data clearly correlated the levels of β-catenin with the prognosis of patients with HER2+ breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.